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Abstract 
In the past decade, scientists and healthcare professionals have gained interest in the 
microbiome and its function as part of the human body. The two most diverse microbiome 
environments are found in the gut and the oral cavity. While the gut microbiome has been 
investigated more deeply and continues to be a great interest, the oral microbiome is in 
comparison a more recent subject with fewer reports on the topic. The purpose of this review 
paper is to highlight the main human systemic diseases associated with the oral microbiome 
and to discuss how our understanding of the oral microbiome’s effect on various diseases 
such as oral cancer, gastrointestinal cancer, diabetes, and periodontal disease with diseases 
has improved. 
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Introduction 
The microbiota makes up majority of cells in the human body, with human cells 
representing only 10% of host cells (Wilson 2008). Symbiotic and commensal 
microorganisms contribute to pathogen resistance, improve the efficiency of the immune 
system, and help with different organ functions (He 2014). The human mouth is the second 
most diverse microbial environment in the body, as it hosts over 700 species of bacteria that 
reside on the surface of teeth and soft tissues of the oral mucosa (Kilian 2016). Oral 
microorganisms can exist in various forms such as viruses, protozoa, fungi, archaea and 
bacteria residing in human oral cavity. Human mouth is heavily colonized by various 
microorganisms and the microbiomes in the oral cavity is the main cause of the most dental 
and periodontal diseases. It is the main reason of people engaging in regular oral hygiene 
practices in order to prevent such diseases. It would be crucial for individuals to maintain 
clean oral health in order to limit the number of oral microbiomes in the oral cavity that could 
possibly cause dental and periodontal diseases (Wade 2013). Oral cavity is primary point to 
enter digestive and respiratory tract. The maladaptation or microbial imbalance in the oral 
cavity is linked with oral inflammation and may lead to systemic diseases in human body 
through microbial pathways such as bacteremia (Han and Wang 2013). Oral microbiomes 
have also proven to present risk factors for human health such as tumor, diabetes mellitus and 
cardiovascular diseases. (He 2014). In this context, the purpose is to further understand the 
correlation between oral microbiome with human health and various systemic diseases. 
 
 
 
 
Oral microbiome and systemic health 
Periodontal disease 
 Periodontal disease can originate from various sources, but the most common source 
would be not maintaining clean oral health, which could trigger pathogens residing in the 
periodontal pocket to cause inflammation (Costalonga 2014). Today, the most common 
database of taxonomy for oral microbiome is HOMD (Human Oral Microbiome Database). It 
consists of 34,573 filtered cloned sequences that also represent possible diseased sites of 
inflammation within the oral cavity (Aas 2005). Different species of the oral microbiome is 
diversified upon the received nutrients and dietary habits of the individuals (Wade 2013). 
Nutrients would shape the symbiosis of the oral microbiome housing on the non-shedding 
surfaces of the teeth in the oral cavity. For example, a person with vegan diet and another person 
with carbohydrate-based diet would have different oral microbiome environment since the 
main nutrient is different and each microbiota would correlate differently according to the main 
source of nutrient.  
The trends in the change of oral microbiome compared between preindustrial samples 
and modern samples would show that the non-pathogenic microbiomes decreased in the 
modern era, and species that are more pathogenic such as S. mutan increased highly, which can 
correlate to increased periodontal disease. (Adler 2013). It is also prevalent that the 
environment and host-genetics can show tremendous difference in oral microbiome 
composition. For example, Eskimo tribes showed lower rate of periodontal disease occurrence 
until more western diet was introduced. (Costalonga 2014). In recent decade, there has been a 
decrease in oral microbiome diversity among different cultures and races. The main 
contribution could be due to reduced resistance to protrusion of pathobionts into the microbial 
environment, which could be caused by globalized food industry (Adler 2013).  
The core site of original adhesion site of oral microbiome would be in the roots of the 
teeth. The roots of the teeth are composed of both salivary and serum proteins and the original 
microbiome would adhere to the protein-rich film on the roots. The non-shedding surface of 
the roots are more complex compared than the enamel portion of the teeth since the enamel is 
only composed of salivary film, which make the non-shedding surface more suitable for the 
oral microbiome to anchor for long-term development (Kolenbrander 2010). As mentioned, the 
supragingival microbial environment would differ from the subgingival microbial environment. 
The supragingival microbial environment would form on the salivary film, but the subgingival 
microbial community would form on protein-rich film, and the subgingival environment would 
be more anaerobic and extreme in pH level and temperature. The different factors contributing 
to the subgingival microbiome would have variation in the composition of species of bacteria 
compared to the supragingival microbiome, which the subgingival microbial environment has 
Streptococcus ssp. and Veillonella as the most prevalent bacteria (Kumar 2011). The bacteria 
in the saliva would originate from various oral tissues and mainly from the tongue. The superior 
surface of the tongue consists mainly of Prevotella and Veillonella, but the inferior surface is 
more prevalent of Streptococcus and Gemella. The salivary microbial environment shows most 
prevalent of Prevotella and Streptococcus (Mager 2003). 
The oral microbial community for healthy individuals has an equilibrium of symbionts 
and pathobiont, which the microbiome would not cause pathogenic effect on the individuals. 
The equilibrium is generally maintained within the microbial environment, although, it can be 
disturbed by various situations (Costalonga 2014). The microbial perturbation caused by 
pathogenic microbiome such as P. gingivalis can disrupt the equilibrium maintained in the oral 
microbiome environment. The perturbation would change the need of the original nutrient in 
the community, which can disrupt both symbionts and pathobionts in the environment 
(Hajishengallis 2014). The specie-specific repression of the host can also alter the quantity of 
either the symbionts or the pathobionts, which can lead to pathogenic effect. The competition 
between different microbial species in the host can also cause the disruption of the equilibrium, 
which can also cause bacteriophagic activity and increase the pathogenic potential within the 
oral microbiome community (Wang 2013).  
The periodontal disease has complex immunological response and innate immunity 
prevents the oral tissue damage caused by the disruption of periodontal tissue homeostasis. The 
T helper cells are the primary cells of the cellular infiltrate in human gingivitis, which the 
phenotype is derived from pathogenic antigen presenting cells such as dendritic cells and 
Langerhans cells (Yamazaki 2003). Change of environment homeostasis within the periodontal 
tissues could be triggered by the perturbation of microbiome or unclear transition of the 
microbial species. During the change, the role of immune response within the gingiva would 
also change. The initial immune response of the gingiva is to recruit and activate the neutrophils 
in order to destruct the pathogenic bacteria. Although, during the change, the immune response 
would cause chronic infiltrate of T, B and plasma cells. The immune cells would be chronically 
infiltrated and cause periodontitis, which would present signs such as vascular proliferation, 
damaged connective tissues, and alveolar bone destruction (Teng 2003). 
It is clearly identified that the CD4 T cells are the primary contributors of alveolar bone 
destruction during the periodontitis. It has been shown through the murine samples that most 
of the mouse with periodontitis showed induced levels of CD4 T cells during the development 
of alveolar bone damage (Baker 1999). Other contributors to osteoclastic activity of alveolar 
bone could be the memory B cells and T cells. The memory B cells, and T cells have been 
identified to release RANK-ligand, type II membrane protein in TNF family that regulate 
apoptosis and differentiate osteoclasts, to induce osteoclastic action within the bone tissue. 
Although, the Th cells would release set of cytokines before the development of alveolar bone 
damage (Takahashi 2005).  
  
Figure 1. Difference between microbial diversity and richness between periodontal health and 
disease. (Costalonga 2014) 
 
Periodontal disease caused by more than one pathogen, which recently derived into 
dysbiosis theory. The theory proposes that the composition shift of low-abundance pathogenic 
species of bacteria such as P. gingivalis, within the oral microbial community in the periodontal 
pocket would alter the host microbial environment that could enhance the destructive 
inflammation and bone destruction. P. gingivalis exist in low quantity but is defined as the 
keystone pathogen for periodontal disease, which can act as a virulence factor to alter and 
depress the host immune response (Hajishengallis 2014). The case of dysbiosis theory work 
with multiple species of microbiome since the mice sample showed that the monocolonization 
of P. gingivalis would not initiate any characteristics of periodontitis. (Hajishengallis 2011).  
Even though, it is prevalent that the P. gingivalis associated with other microbial 
bacteria would cause the periodontal diseases, the specificity of the microbial composition and 
measurement of progression of the periodontal disease is still unclear (Costalonga 2014). 
Oral cancer 
Among all American patients diagnosed with oral cancer every year, about 90 percent 
of the patients have oral squamous cell carcinoma. The survival rate of the squamous cell 
carcinoma is about 40 percent, which has not been improved over 40 years (Parkin 1999). 
While tobacco and alcohol usage are the main contributors to the developmental oral carcinoma, 
many patients with oral cancer have not been exposed to tobacco and alcohol consumption 
(Schmidt 2004). As oral carcinoma is associated with various routes of infection, the oral 
microbiome may contribute to the formation of oral squamous cell carcinoma in different forms 
of pathogenesis such as viruses and bacteria (Al-Hebshi 2019). 
 Classically the majority of carcinogens for oral cancer are known to be viruses, 
especially Human papillomaviruses and Human herpesviruses (Al-Hebshi 2019). Human 
papilloma viruses are highly associated with oropharyngeal cancer. The high-risk (hr)  HPVs 
are known to be the main cause of the oropharyngeal cancer, where the HPV E6 and HPV E7 
oncogenes inhibit the p53 and Rb (retinoblastoma) gene proteins in the posterior third of the 
tongue to block the tumor suppressing action of the p53 and Rb gene proteins (Johnson 2018). 
Epstein-Barr virus was known to be the main contributor for the nasopharyngeal cancer, but 
there are not enough evidence to show that the Epstein-Barr virus plays the major role causing 
oral cancer (Johnson 2018). The more evident role of Herpes simplex viruses HSV-1 and HSV-
2 were found contributing to oral squamous cell carcinoma, but pathogenic mechanism is 
unknown (Al-Hebshi 2019). Along with the viruses, there are oral bacteria that also influence 
the pathogenicity of the oral carcinoma. 
 The interest in oral bacterial contribution to oral cancer has been emerging recently. 
Among the bacterial community in oral microbiome, the two bacteria that are thought to be 
most influential are periodontal bacteria Porphyromonas gingivalis and Fusobacterium 
nucleatum (Al-Hebshi 2019). P. gingivalis induce carcinoma in various ways including 
activation of JAK1/STAT3 and PI3K/Akt signaling pathways, blocking the caspase-3 and 
caspase-9 activity (Mao 2007), and preventing the ATP-dependent P2X7-mediated apoptosis 
(Yilmaz 2008). Both P. gingivalis and F. nucleatum downregulate the amount of p53 
tumor suppressor gene and upregulate kinases and cyclins to induce the cell proliferation (Al-
Hebshi 2019). P. gingivalis and F. nucleatum induce the production of pro-inflammatory 
cytokines, which will lead to increased chronic inflammation that could contribute to the 
development of oral cancer (Andrian 2004, Kostic 2013). Other factors, like production of 
acetaldehyde, could also play a major role in progression of oral cancer, which is highly 
associated with other bacterial species of the oral microbiome, such as Streptococcus spp. and 
Neisseria spp. (Al-Hebshi 2019). 
 
  
Figure 2. Effect of different bacterial species in the oral microbiome  
that may induce the progression of oral cancer through various mechanisms.  
(Perera 2016) 
 
 Variations in bacterial composition occur in oral cancer mainly because different 
species of bacteria can play a similar function in the community, and thus are able to substitute 
for each other. This is known as functional redundancy, which can explain the composition 
differences associated with oral cancer (Tian 2017). Metatranscriptome sequencing has been 
used to monitor the transcriptional activity and gene expression of the oral microbiome in 
correlation with oral squamous cell carcinoma. The result from the study showed that the 
oncogenic bacteriomes had induced primary pro-inflammatory features, such as 
lipopolysaccharide biosynthesis, high production of peptidases, flagella assembly, and bacterial 
chemotaxis (Yost 2018). The conceptual model called “passenger-turning-driver” model lays 
out the function of the oral microbiome in oral cancer, which is not to initiate the disease. The 
initial intra-tumor microbiome would be more advantageous at combining with the tumor 
microenvironment to express pro-inflammatory features. The expression would lead to 
functioning (“driver”) intra-tumor microbiome that would induce the progression of oral cancer 
through chronic inflammation of the cells (Al-Hebshi 2019).  
 
Figure 3. “Passenger-turning-driver” conceptual model that explains the progression of oral 
microbiome with the tumor microenvironment. The oral microbiome would not initiate the oral 
cancer, but it would be advantageously chosen by the tumor-microenvironment to create pro-
inflammatory features. The passenger intra-tumor microbiome would be turned into driver intra-tumor 
microbiome after the pro-inflammatory expression, thus leading to chronic progression of tumors in 
the oral cavity (Al-Hebshi 2019). 
Gastrointestinal cancer 
Gastrointestinal cancer risk from oral microorganism is associated with the oral 
bacteria that leads to the development of periodontal disease and tooth loss in the oral cavity, 
which these relationships tend to consider significant factors such as smoking, body mass index, 
and socioeconomic status (Meyer 2008). Oral microbiota may affect oral and gastrointestinal 
cancer risk through two main contributing factors, which are local activation of alcohol and 
smoking carcinogens. Ethanol is not a strong carcinogen, but the oral bacteria are capable to 
convert the ethanol to acetaldehyde, which is a recognized human carcinogen, leading to 
carcinogenic acetaldehyde exposure to oral and gastrointestinal tract. Mutagenic quantity of 
acetaldehyde can be detected from saliva after consumption of alcohol (Ahn 2012).  
 
Figure 4. Oral bacteria in alcohol metabolism. Under normal physiological 
conditions, ethanol is metabolized to acetaldehyde by alcohol 
dehydrogenase (ADH), and acetaldehyde is further metabolized to 
acetic acid by aldehyde dehydrogenase (ALDH). Oral bacteria have 
the capacity to convert ethanol to acetaldehyde, a genotoxin, leading 
to extended acetaldehyde exposure of the oral and gastrointestinal 
tract, following alcohol use, and possibly potentiated by smoking (Ahn 2012). 
Oral bacteria may also take part in induced activation of carcinogenic nitrosamines 
from smoking tobacco (Yang 2011). The oral microbiota activates the tobacco smoke 
nitrosamine, nitrosodiethylamine (NDEA) to hydroxylated product, which is strongly 
carcinogenic to human. Tobacco smoking can also lead to increased production of acetaldehyde 
by oral bacteria, potentially contributing to both production of acetaldehyde and nitrosamines.  
The antiseptic mouthwash chlorohexidine can reduce the presence of salivary 
acetaldehyde level and nitroso-amino acid formation and secretion in saliva and urine. Usage 
of chlorohexidine prior to ethanol consumption lead to 50% decrease in salivary acetaldehyde 
level (Homann 1997). The chlorhexidine also decreased the level of nitroso-amino acid 
formation and excretion in saliva and urine by 30% (Shapiro 1991). The oral microorganisms 
leading to gastrointestinal disease show strong relation to periodontal disease.  
Although, the systemic disease is involved with oral microbiome-related 
carcinogenesis, it is much clearer that the periodontal disease has greater association with the 
systemic effects leading to the cancer (Ahn 2012). The successful treatment of the periodontal 
disease caused by oral microorganism found in atherosclerotic plaque, have led to reversal 
effect of the systemic diseases. The treatment induced the endothelial function and decreased 
inflammatory markers (Tonetti 2007), which explain the strong correlation between periodontal 
disease and gastrointestinal cancer. Oral and gut microbiome structure may be different in the 
same individual, but oral microbiome can enter the GI tract (Ahn 2012). In addition, the oral 
bacteria can provide ligands for toll-like receptors at target membrane receptors. The toll-like 
membrane receptors are on innate immune cells that bind structural molecules derived from 
microorganisms and potentially link inflammatory response down the cell-signaling pathway 
to other human bacteria. More evidence is forming that immune response to chronic exposure 
to bacteria and its toxins may be the critical portion in oral and gastrointestinal carcinogenesis 
(Pizzo 2010).  
 
Diabetes 
Diabetes is also known as type 1 or type 2 diabetes, which is a clinical disease 
characterized by hyperglycemia due insufficient or deficient secretion of insulin or reduced 
insulin function by other factors (Alberti and Zimmet 1998). Diabetes show a bidirectional 
relationship with periodontal disease and oral microbiome is associated with homeostasis and 
affects various pathologic processes (Iwai 2009). Diabetes can also be a risk factor for 
periodontitis, and it may induce the severity of the disease progression. The severity of 
periodontitis disease would increase heavily in type 1 diabetes and the age would also be a 
great risk factor for periodontitis (Cullinan 2001). Type 2 diabetes would increase the risk for 
periodontitis since type 2 diabetes is also a great risk factor for periodontitis (Emrich 1991).  
  
Figure 5. Graphical abstract of difference shown between normal, diabetic, and diabetic IL-17 absent 
mice associated with oral microbiome (Xiao 2017). 
 
 
As the diabetes increase the risk of periodontitis, the risk and severity of tooth loss 
would also increase among the diabetics. The oral microbiota from a diabetic mouse would 
cause a shift in oral bacterial composition, which would make the oral microbiota of diabetic 
more pathogenic compared to the disease-free mice. In addition, the treatment of IL-17 
antibody has shown to decrease the pathogenicity of the oral microbiota in diabetic mice. The 
oral microbiota from IL-17-treated donors increased the rate of reduced neutrophil recruitment, 
reduced IL-6 and less bone resorption. Diabetes-enhanced IL-17 changed the oral microbiota 
composition in the oral cavity of the recipient mice and became more pathogenic (Xiao 2017). 
The composition of subgingival dental plaque in diabetics were shown different 
compared to the non-diabetics. The 16S rRNA sequencing was used to observe the difference 
in subgingival microbiota between type 2 diabetics and non-diabetics. Significant difference 
was observed by showing diabetics presenting higher abundance of TM7, Aggregatibacter, 
Neisseria, Actinomyces, Capnocytophaga, Gemella, Eikenella, Selenomonas, Fusobacteriu, 
Veillonella, and Streptococus, F. Nucleatum, V. Parvula, Veillonella dispar, and E. corrodens 
(Casarin 2013). Considering the hyperglycemia in subgingival microorganism and altered 
immune response, the subgingival difference between diabetics and non-diabetics could be the 
potential risk factor for pathogenicity in oral microbiome due to dysbiosis of oral 
microorganisms in diabetics.  
 
 
 
 
 
 
 
Discussion 
 The oral microbiome community is diverse and shown to be related to multiple 
systemic diseases. The microbial bacteria can be a primary cause to a certain disease, but it can 
also help to induce multiple diseases through various ways such as prolonging the inflammation 
or triggering series of effects that would lead to a progression of a disease. An oral related 
disease such as periodontal disease and oral cancer could be directly affected by the primary 
action of the oral microbiota, which would aid to cause the diseases in human. Other non-oral 
related diseases such as gastrointestinal cancer and diabetes would be affected by the microbial 
environment that could alter the progression of the diseases or prolong the chronic effect related 
to the diseases. 
 
 
 
 
 
 
 
 
 
 
 
Future work 
More methodology and pathway can be determined through research and further analysis of 
oral microbiota can be done through clinical data and experimental data. Especially, 
determining how the oral microbiome would transfer over to affect other system diseases such 
as GI cancer and diabetes could be deeply researched. More methods could be identified since 
many of mentioned diseases lack specific methods of progression and deeper progression 
relationship between the diseases and oral microbiome. 
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